These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 22045993)
1. Governments pledge to clamp down on counterfeit drugs. Watson R BMJ; 2011 Nov; 343():d7096. PubMed ID: 22045993 [No Abstract] [Full Text] [Related]
2. Multi-level governance: The way forward for European illicit drug policy? Chatwin C Int J Drug Policy; 2007 Dec; 18(6):494-502. PubMed ID: 18061875 [TBL] [Abstract][Full Text] [Related]
3. [Drugs over the borders]. Thirstrup S Ugeskr Laeger; 2011 Oct; 173(42):2633. PubMed ID: 22027160 [No Abstract] [Full Text] [Related]
5. WHO to set up international task force on counterfeit drugs. Zarocostas J BMJ; 2006 Feb; 332(7539):444. PubMed ID: 16497756 [No Abstract] [Full Text] [Related]
6. The international (mainly European) attitude to the drug driving problem--legislation and countermeasures. Irving A Int Clin Psychopharmacol; 1988 May; 3 Suppl 1():13-21. PubMed ID: 3403945 [No Abstract] [Full Text] [Related]
7. [European Network of Official Medicines Control Laboratories : International OMCL Working Group Combating Counterfeit and other Illegal Medicines]. Wanko R; Unkelbach U Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1221-1227. PubMed ID: 28921172 [TBL] [Abstract][Full Text] [Related]
8. Defeat of antipiracy treaty is hailed as victory for generic drugs. Moszynski P BMJ; 2012 Jul; 345():e4660. PubMed ID: 22777031 [No Abstract] [Full Text] [Related]
9. 2000: the drug problem in the European Union. Murphy JF Ir Med J; 2000 Dec; 93(9):260. PubMed ID: 11209906 [No Abstract] [Full Text] [Related]
10. [Drugs after 1992; a comparison with yet many unknowns]. Boer EJ Ned Tijdschr Geneeskd; 1990 Sep; 134(38):1863-7. PubMed ID: 2215761 [No Abstract] [Full Text] [Related]
11. [The Working Group of Enforcement Officers (WGEO) : The European Network of Drug Regulatory Authorities to Combat Pharmaceutical Crime]. Wittstock M; Streit R Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1228-1232. PubMed ID: 28980025 [TBL] [Abstract][Full Text] [Related]
12. Do international model drug control laws provide for drug availability? University of Wisconsin Pain & Policy Studies Group J Pain Palliat Care Pharmacother; 2009; 23(2):145-52. PubMed ID: 19492215 [TBL] [Abstract][Full Text] [Related]
13. Health and economic consequences of counterfeit drugs. Seiter A Clin Pharmacol Ther; 2009 Jun; 85(6):576-8. PubMed ID: 19451909 [TBL] [Abstract][Full Text] [Related]
14. All the players in the game: driving home the global commitment for legitimate drugs. Babyar J Drug Dev Ind Pharm; 2018 Nov; 44(11):1868-1870. PubMed ID: 30114946 [TBL] [Abstract][Full Text] [Related]
15. Understanding and fighting the medicine counterfeit market. Dégardin K; Roggo Y; Margot P J Pharm Biomed Anal; 2014 Jan; 87():167-75. PubMed ID: 23384475 [TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical regulation in the single European market. Matthews D; Wilson C Med Law; 1998; 17(3):401-27. PubMed ID: 9922630 [TBL] [Abstract][Full Text] [Related]